1035229-31-2 Usage
Uses
Used in Organic Synthesis:
1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone is used as an intermediate in organic synthesis for the preparation of various complex organic molecules. Its structural features, including the benzyl ether and nitro group, make it a versatile building block for the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone is used as a starting material for the development of new drugs. Its potential biological properties, such as antioxidant and anti-inflammatory activities, make it a promising candidate for the treatment of various diseases and conditions. Additionally, the presence of the nitro group suggests that 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone may have pharmacological and medicinal properties that can be further explored and optimized.
Used in Antioxidant and Anti-inflammatory Applications:
1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone is used as an antioxidant and anti-inflammatory agent due to its strong activities in these areas. Its antioxidant properties can help protect cells from oxidative stress and damage, while its anti-inflammatory effects can alleviate inflammation and reduce the associated symptoms. This makes it a valuable compound for the development of therapeutic agents targeting conditions such as arthritis, atherosclerosis, and neurodegenerative diseases.
Used in Drug Discovery:
In the field of drug discovery, 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone is used as a lead compound for the identification and optimization of new drug candidates. Its unique chemical structure and potential biological activities provide a foundation for the design and synthesis of novel therapeutic agents with improved efficacy and selectivity. Researchers can modify and optimize the structure of 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone to develop drugs with specific targets and mechanisms of action, ultimately leading to the discovery of new medicines for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1035229-31-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,2,2 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1035229-31:
(9*1)+(8*0)+(7*3)+(6*5)+(5*2)+(4*2)+(3*9)+(2*3)+(1*1)=112
112 % 10 = 2
So 1035229-31-2 is a valid CAS Registry Number.
1035229-31-2Relevant academic research and scientific papers
SMYD2 INHIBITORS
-
, (2016/02/20)
The present disclosure generally relates to compounds having cellular anti-proliferative activities, and more particularly relates to compounds which inhibit the activity of human SMYD2, a SET and MYND domain-containing protein lysine methyltransferase.
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
Sweis, Ramzi F.,Wang, Zhi,Algire, Mikkel,Arrowsmith, Cheryl H.,Brown, Peter J.,Chiang, Gary G.,Guo, Jun,Jakob, Clarissa G.,Kennedy, Steven,Li, Fengling,Maag, David,Shaw, Bailin,Soni, Nirupama B.,Vedadi, Masoud,Pappano, William N.
, p. 695 - 700 (2015/06/30)
A lack of useful small molecule tools has precluded thorough interrogation of the biological function of SMYD2, a lysine methyltransferase with known tumor-suppressor substrates. Systematic exploration of the structure-activity relationships of a previous
BENZOXAZINONE DERIVATIVES ACTING AS BETA2-ADRENORECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISORDERS
-
, (2010/01/12)
The present invention provides a compound of formula (I), wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES
-
Page/Page column 84, (2008/12/06)
The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4', R5', R6, R7, A, D, m and E are as defined in the specification, processes
